A lengthy article in the January edition of Vanity Fair magazine, “Danger in the Ring” highlights the plight of thousands of women who have adverse events such as linked to the NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) birth control device manufactured by Merck. The magazine asks the question, “Is the Contraceptive NuvaRing Killing Thousands?”
NuvaRing is a vaginal ring that releases low doses of estrogen and progestin over three weeks which prevents ovulation. A new study links an increased risk of venous thrombosis in women who use the birth control device.
The Vanity Fair article profiles the tragic death of Erika Langhard, a brilliant 24-year-old student, who died of a pulmonary embolism — a blockage of the main artery of the lung caused by a blood clot — linked to NuvaRing.
The article is heartbreaking including comments included at the end of the article from readers such as this one:
The first lawsuit against NuvaRing is scheduled for April of 2014 and the plaintiffs in the lawsuit claim that Merck has downplayed the risk associated with the device and the injuries and the deaths. There are more than 3,600 lawsuits filed against Merck and according to one article that we read, more than 100 deaths associated with the device. You can read a Danish study, Venous thrombosis in users of non-oral hormonal contraception” here. This research study assesses the risk of venous thrombosis in women who use non-oral hormonal contracpetion.
The Farber Law Group is currently speaking with women who have been seriously injured and the families of women who have died while using NuvaRing contraceptive medication.
NuvaRing Side Effects
If you or a loved one has experienced any of the side effects associated with the contraceptive, you may be seeking answers to your legal questions. Side effects including thrombosis, heart attack, blood clots, stroke or toxic shock syndrome are some of the serious complications associated with the device.